Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
Editor in chief Professor Stefan Agewall said: “We aim to become the number one journal in the field of clinical cardiovascular pharmacology within a couple of years. The strength of this journal is being part of the ESC journal family with the EHJ as the mother journal. Currently there is no daughter journal covering clinical pharmacology and there is a need for one. Neither are there similar daughter journals from Circulation or JACC.”
Professor Agewall continued: “Pharmacology is an extremely important part of cardiology today. Nearly every patient with cardiac disease is on some kind of medication. Already there are almost half a million references to ‘cardiovascular pharmacology’ in MEDLINE and the number of papers within this area is growing very fast. More studies are needed to improve outcomes of patients with cardiovascular disease which is the most common cause of death globally.”
He concluded: “European Heart Journal – Cardiovascular Pharmacotherapy will hopefully soon be the leading journal in this particular area of cardiology. We will be the place to go for the latest developments and expert comment in this rapidly expanding and exciting field.”
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved